{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:59Z","timestamp":1792425539189,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.09.053","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T17:34:40Z","timestamp":1510853680000},"page":"6591-6593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"PB","title":["Enhancing the role of vaccines in combatting antimicrobial resistance"],"prefix":"10.1016","volume":"35","author":[{"given":"Charles","family":"Clift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Salisbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.053_b0005","unstructured":"Boston Consulting Group, Federal Ministry of Health. Breaking through the Wall: a call for concerted action on antibiotics research and development. Berlin; 2017. <http:\/\/www.bcg.de\/documents\/file219507.pdf>."},{"key":"10.1016\/j.vaccine.2017.09.053_b0010","unstructured":"Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. London; 2016. <https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf>."},{"key":"10.1016\/j.vaccine.2017.09.053_b0015","unstructured":"Review on Antimicrobial Resistance. Vaccines and alternative approaches: reducing our dependence on antimicrobials. London; 2016. <https:\/\/amr-review.org\/sites\/default\/files\/Vaccines%20and%20alternatives_v4_LR.pdf>."},{"key":"10.1016\/j.vaccine.2017.09.053_b0020","unstructured":"Chatham House. Meeting summary: the value of vaccines in the avoidance of antimicrobial resistance. London; 2017. https:\/\/www.chathamhouse.org\/sites\/files\/chathamhouse\/events\/2017-03-30-amr-vaccines-meeting-summary.pdf."},{"issue":"9","key":"10.1016\/j.vaccine.2017.09.053_b0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/cid\/ciw067","article-title":"Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine","volume":"62","author":"Tomczyk","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.053_b0030","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"New Engl J Med"},{"issue":"17","key":"10.1016\/j.vaccine.2017.09.053_b0035","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.053_b0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/605087","article-title":"The effect of universal influenza immunization on antibiotic prescriptions: an ecological study","volume":"49","author":"Kwong","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.053_b0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13756-016-0121-8","article-title":"Re-emergence of the susceptibility of the Salmonella spp. isolated from blood samples to conventional first line antibiotics","volume":"5","author":"Shrestha","year":"2016","journal-title":"Antimicrobial Resist Infect Control"},{"key":"10.1016\/j.vaccine.2017.09.053_b0050","doi-asserted-by":"crossref","unstructured":"H. Petousis-Harris et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand \u2013 a retrospective case control study Lancet 2017. https:\/\/doi.org\/10.1016\/S0140-6736(17)31449-6.","DOI":"10.1016\/S0140-6736(17)31449-6"},{"key":"10.1016\/j.vaccine.2017.09.053_b0055","unstructured":"World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. Press release. Geneva; February 2017. <http:\/\/www.who.int\/mediacentre\/news\/releases\/2017\/bacteria-antibiotics-needed\/en\/>."},{"key":"10.1016\/j.vaccine.2017.09.053_b0060","unstructured":"Review on Antimicrobial Resistance. Antimicrobials in agriculture and the environment: reducing unnecessary use and waste. London; 2015. <https:\/\/amr-review.org\/sites\/default\/files\/Antimicrobials%20in%20agriculture%20and%20the%20environment%20-%20Reducing%20unnecessary%20use%20and%20waste.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T07:23:18Z","timestamp":1570346598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":12,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17313014"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the role of vaccines in combatting antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}